Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Colonic Polyps 2 Breast Neoplasms 2 Rectal Diseases 1 Prostatic Neoplasms 1 Pneumoperitoneum 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Lung Cancer Metastatic 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Gastric Subepithelial Tumor 1 Erectile Dysfunction 1 Endometriosis 1 Diverticulitis 1 Crohn Disease 1 Constipation 1 Colorectal Neoplasms 1 Colonic Diseases 1 Colitis, Ulcerative 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bites and Stings 1 Bile Duct Neoplasms 1 Agnosia 1

Interventions

Carboplatin 779 Pemetrexed 606 Cisplatin 543 Paclitaxel 490 pembrolizumab 461 Docetaxel 440 Gemcitabine 328 Erlotinib Hydrochloride 307 Radiotherapy 255 Nivolumab 244 Bevacizumab 233 osimertinib 177 Drug Therapy 164 durvalumab 157 atezolizumab 135 Gefitinib 134 Radiosurgery 131 Vinorelbine 111 Cetuximab 97 130-nm albumin-bound paclitaxel 93 Ipilimumab 86 Magnetic Resonance Spectroscopy 83 Taxes 79 Surgical Procedures, Operative 74 Afatinib 68 Albumin-Bound Paclitaxel 66 Specimen Handling 61 Etoposide 61 Cyclophosphamide 60 tislelizumab 59

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Surgical Instruments × Clear all

NCT05478538 2026-04-29

CYBRID-01

Elephas

Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡